Adenosine deaminase inhibition for immunosuppression.

Suppr

超能文献

作者信息

Chassin M M, Chirigos M A, Johns D G, Adamson R H

出版信息

N Engl J Med. 1977 May 26;296(21):1232.

PMID:854065

Abstract

摘要

相似文献

Adenosine deaminase inhibition for immunosuppression.

N Engl J Med. 1977 May 26;296(21):1232.

Effects of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nornyl)adenine on plasma levels and urinary excretion of 9-beta-D-arabinofuranosyladenine in the mouse 1,2,3.

Cancer Treat Rep. 1978 Mar;62(3):369-73.

Inhibition for immunosuppression.

N Engl J Med. 1977 Apr 7;296(14):819. doi: 10.1056/NEJM197704072961417.

Studies of the relationship between adenosine deaminase and immune function.

J Immunol. 1977 Aug;119(2):675-8.

Therapeutic effects of 9-beta-D-arabinofuranosyladenine and 2'-deoxycoformycin combinations on intracerebral leukemia.9-β-D-阿拉伯呋喃糖基腺嘌呤与2'-脱氧助间型霉素联合用药对脑内白血病的治疗作用

Cancer Res. 1977 Jul;37(7 Pt 1):1953-5.

Inhibition of brain adenosine deaminase by 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl) adenine.

J Neurochem. 1978 Jun;30(6):1479-82. doi: 10.1111/j.1471-4159.1978.tb10496.x.

Inhibition of adenosine deaminase and purine nucleoside phosphorylase and T-cell function in germfree mice and human peripheral blood.无菌小鼠和人外周血中腺苷脱氨酶、嘌呤核苷磷酸化酶的抑制作用及T细胞功能

Prog Clin Biol Res. 1985;181:461-6.

Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin.

Pharmacology. 1977;15(1):84-9. doi: 10.1159/000136666.

Toxicities of adenosine and 2'-deoxyadrenosine in L cells treated with inhibitors of adenosine deaminase.

Biochem Pharmacol. 1977 Jan 1;26(1):71-6. doi: 10.1016/0006-2952(77)90135-6.

Low-toxicity immunosuppression by specific inhibition of adenosine deaminase (ADA): prolongation of mouse skin grafts with erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).

Surg Forum. 1977;28:320-2.

引用本文的文献

Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.腺苷脱氨酶抑制剂：它们在化疗和免疫抑制中的作用。

Cancer Chemother Pharmacol. 1980;4(4):227-35. doi: 10.1007/BF00255266.

The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.腺苷脱氨酶抑制剂2'-脱氧助间型霉素的临床药理学。

Cancer Chemother Pharmacol. 1980;5(2):93-101. doi: 10.1007/BF00435411.

Animal model for immune dysfunction associated with adenosine deaminase deficiency.与腺苷脱氨酶缺乏相关的免疫功能障碍动物模型。

Proc Natl Acad Sci U S A. 1980 Aug;77(8):4899-903. doi: 10.1073/pnas.77.8.4899.

Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.嘌呤生成性淋巴细胞毒性：腺苷脱氨酶抑制剂更广泛化疗潜力的线索。

Cancer Chemother Pharmacol. 1983;10(2):73-8. doi: 10.1007/BF00446213.

Role of adenosine deaminase in activation of macrophages.腺苷脱氨酶在巨噬细胞激活中的作用。

Infect Immun. 1981 Apr;32(1):394-7. doi: 10.1128/iai.32.1.394-397.1981.

Inhibition of lymphocyte response to mitogens by dipyridamole: preliminary findings.

Eur J Clin Pharmacol. 1985;28(3):263-5. doi: 10.1007/BF00543321.

Combined immunodeficiency and inborn errors of purine metabolism.联合免疫缺陷与嘌呤代谢先天性缺陷

Blut. 1978 Oct 13;37(4):173-81. doi: 10.1007/BF00996718.

Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.缺乏腺苷脱氨酶活性的小鼠腹膜巨噬细胞的嘌呤排泄

Proc Natl Acad Sci U S A. 1979 Feb;76(2):925-9. doi: 10.1073/pnas.76.2.925.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验